Generate Biomedicines, Inc. GENB

Set alert

14.16 USD +0.31 (+2.24%)

At closeNov 4, 2026, 6:25 PM EST

14.34 +0.18 +1.27%

After hours · Nov 4, 6:25 PM ET

13.40 Day range 14.34

11.00 52-week range 22.67

Held by insiders 14.05%

Held by institutions 79.09%

Float held by institutions 92.02%

Institutions 134

Top institutional holders
Holder	% held	Shares	Value	Reported
Flagship Pioneering LLC	48.83%	62,673,117	887.45M	Jun 29, 2026
FMR, LLC	4.07%	5,221,599	73.94M	Jun 29, 2026
Capital World Investors	3.28%	4,215,632	59.69M	Jun 29, 2026
Braidwell LP	2.56%	3,283,844	46.50M	Jun 29, 2026
Price (T.Rowe) Associates Inc	1.68%	2,156,627	30.54M	Jun 29, 2026
NORGES BANK	1.63%	2,094,616	29.66M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
SmallCap World Fund Inc	2.92%	3,752,630	53.14M	Sep 29, 2026
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund	1.70%	2,186,392	30.96M	Aug 30, 2026
ARK ETF Trust-ARK Genomic Revolution ETF	1.22%	1,571,881	22.26M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	0.64%	816,876	11.57M	Jun 29, 2026
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund	0.54%	695,890	9.85M	Aug 30, 2026
iShares Trust-iShares Russell 2000 ETF	0.50%	636,804	9.02M	Sep 29, 2026

GENB insiders
Insider	Relation	Latest transaction	Date	Shares held
AFEYAN NOUBAR BOGHOS	Director and Beneficial Owner of more than 10% of a Class of Security	Purchase	Mar 1, 2026	0
ARNOLD FRANCES H PH.D.	Director	Sale	Aug 31, 2026	463,944
BANCEL STEPHANE J	Director	Conversion of Exercise of derivative security	Mar 1, 2026	0
GROUS BETH	Officer	Purchase	Mar 1, 2026	0
MENDILLO JANE L.	Director	Purchase	Mar 1, 2026	1,500
NALLY MICHAEL	Chief Executive Officer	Purchase	Mar 3, 2026	2,889,150

Held by funds